Search clinical trials for: HIV risk

Total 27555 results

Columbia University
National Institute of Mental Health (NIMH)

Completed

A Combination HIV Prevention Strategy for Young Women at Risk for HIV (IPrEP)

Human Immunodeficiency Virus

Kenya
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

HIV Infections

United States, Kenya, South Africa, Thailand
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Trauma Informed Prevention for Substance Use and Risky Sex (TIPS)

HIV/AIDS | Substance Use

United States
University of Maryland, College Park

Completed

SAVA Syndemic Risk Reduction for African American Couples

SAVA

United States
Ann & Robert H Lurie Children's Hospital of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Employing eSBI in HIV Testing for At-risk Youth

HIV | Substance Use

United States
PATH
Mahidol Oxford Tropical Medicine Research Unit

Terminated

Assessing a Risk Model for G6PD Deficiency

Malaria, Vivax | G6PD Deficiency

Thailand
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

HIV Infections

United States, Malawi, South Africa, Zambia, Zimbabwe
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group; HIV Prevention Trials Network

Completed

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

HIV Infection

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA)

Terminated

Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users

HIV Infections | Opioid-Related Disorders

China, Thailand
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection

HIV Infections

United States, Thailand, Puerto Rico, Brazil, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

HIV Infections

United States
Medical College of Wisconsin
National Institute of Mental Health (NIMH)

Enrolling by invitation

HIV Prevention Among At-risk Latinos in the Heartland

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Schering-Plough

Completed

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

HIV Infections | Lymphoma, Non-Hodgkin

United States
National Institute of Allergy and Infectious Diseases...

Completed

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

HIV Infections | Lymphoma, Non-Hodgkin

United States
Yale University
National Institute of Allergy and Infectious Diseases (NIAID); Kenyatta National... and other collaborators

Completed

High-yield HIV Testing, Facilitated Linkage to Care, and Prevention for Female Youth in Kenya (GIRLS)

HIV | Adolescent Behavior

Kenya
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

HIV Infections

United States
University of Louisville
James Graham Brown Cancer Center

Active, not recruiting

Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients (DTIC)

Metastatic Melanoma

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Public Health Foundation Enterprises, Inc.
National Institute of Mental Health (NIMH); Emory University; San Francisco Department... and other collaborators

Completed

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

Risk Behavior | HIV Prevention | Adherence, Medication | Pre-Exposure Prophylaxis

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals

HIV Infections | Neurosyphilis

United States
University of California, San Diego
Comisión de Salud Fronteriza México-Estados Unidos (CSFMEU)

Completed

Texting Intervention to Sustain HIV Prevention in Women in High-drug-use Contexts

HIV | Chlamydia | Gonorrhea | Syphilis

Mexico
Boston Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs (SCRIPT)

HIV Infections | Substance Use | Stigmatization

Russian Federation
Johns Hopkins Bloomberg School of Public Health
Baltimore City Health Department

Completed

Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women (PEARL)

HIV/AIDS

United States
Hunter College of City University of New York
National Institute on Drug Abuse (NIDA)

Completed

Couples Health Project: Couples-based Intervention to Reduce Drug Use and HIV Transmission Risk (CHP)

Risk Behavior | Drug Use | Sex, Anal

United States
University of South Carolina
Duke University; Kilimanjaro Christian Medical Centre, Tanzania

Completed

Does Preference-based HIV Testing Increase Uptake in High Risk Populations? (DCE-IMPACT)

HIV Testing

United States, Tanzania
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

High Risk Neuroblastoma

United States
University of Miami
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men (HOLAHIV)

Human Immunodeficiency Virus | Cardiometabolic Risk

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Adapting an Evidence-based Intervention for Stigma-related Stress, Mental Health, and HIV Risk for MSM of Color in Small Urban Areas (ESTEEM-conneCT)

HIV in MSM

United States
Yale University

Completed

Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks

HIV Infections

United States
Guy's and St Thomas' NHS Foundation Trust
Gilead Sciences; ViiV Healthcare

Completed

The Role of Home Packs of HIV PEPSE in High Risk Individuals (Home PEPSE)

HIV-1-infection

United Kingdom
Abramson Cancer Center of the University of Pennsylvania

Completed

Intraoperative Imaging With ICG Registry

Lung Nodule, Breast, Kidney,Parathyroid, Mediastinal, Skin Mass, Soft Tissue, Prostate, Stomach Pleural, Head and Neck, and Are at Risk of Recurrence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

Opiate Dependence

United States, Malaysia
Johns Hopkins University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women (AIMS)

Microbial Colonization

United States
University of North Carolina, Greensboro

Completed

A Risky Sex Prevention Intervention for Middle School Age Minority Girls (GEMM)

HIV | Risky Sex Prevention

United States
Medical College of Wisconsin
National Institute on Drug Abuse (NIDA)

Completed

High Risk Crack Use Settings and HIV in El Salvador (Encuentro)

Sexually Transmitted Diseases | HIV

El Salvador
Public Health Foundation Enterprises, Inc.
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men

Sexually Transmitted Diseases | HIV | Risk Reduction | Pre-Exposure Prophylaxis

United States
University of Southern California

Completed

Rice Bran Supplementation in Treated HIV Infection (BRM4)

Inflammation in HIV Infection

United States
University of South Carolina
National Institute of Nursing Research (NINR)

Completed

Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk

Cardiovascular Diseases | Obesity | Hyperlipidemia

United States
Groupe Hospitalier Paris Saint Joseph

Withdrawn

OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome (OUTCOV)

COVID
Public Health Foundation Enterprises, Inc.
University of California, San Francisco; California HIV/AIDS Research Program; San Francisco Department of Public Health and other collaborators

Completed

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

Transgender Persons | Pre-Exposure Prophylaxis

United States
Public Health Foundation Enterprises, Inc.
National Institute of Mental Health (NIMH); Emory University; San Francisco Department... and other collaborators

Completed

DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men

Risk Behavior | HIV Prevention | Adherence, Medication | Pre-Exposure Prophylaxis

United States
Public Health Foundation Enterprises, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Completed

HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing

Sexually Transmitted Diseases | HIV Prevention | Pre-Exposure Prophylaxis

United States
Oregon Health and Science University
University of Georgia

Active, not recruiting

Telephone Counseling to Enhance the Quality and Safety of Romantic and Sexual Relationships in People Living and Aging With HIV

HIV Seropositivity

United States
Prisma Health-Upstate
Albert Einstein College of Medicine; Clemson University

Completed

Intensive Models of HCV Care for Injection Drug Users

Hepatitis C | Medication Adherence

United States
University of California, San Francisco
Centers for Disease Control and Prevention; Makerere University; Infectious Diseases...

Completed

Rapid HIV Viral Load Monitoring in High Risk Patients In Uganda (RAPID-VL)

HIV

Uganda
National Cancer Institute (NCI)

Completed

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

Kaposi's Sarcoma

Italy
University of Connecticut

Completed

Brief HIV Prevention Counseling for STI Patients in South Africa

Sexually Transmitted Infections

United States
Boston University
National Institute on Drug Abuse (NIDA)

Withdrawn

Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)

Intravenous Drug Abuse
The Miriam Hospital

Enrolling by invitation

Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV Infection

HIV Infections | Sexually Transmitted Diseases

United States

Search clinical trials for: HIV risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations